EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The dopamine transporter inhibition using GBR 12909 as a novel pharmacological tool to assess bipolar disorder-like neurobehavioral phenotypes in zebrafish

Julia Canzian, João V Borba, Cássio M Resmim, Khadija A Mohammed, Camilla W Pretzel, Isaac A Adedara, Denis B Rosemberg

Behavioural Brain Research · 2025

DOI: 10.1016/j.bbr.2024.115302 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Behavioural Brain Research, 2025. Verfasst von Julia Canzian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal Universit…. Hauptthemen laut MEDLINE: Zebrafish, Bipolar Disorder, Dopamine Plasma Membrane Transport Proteins, Disease Models, Animal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 132 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Coordination of Higher Education Personnel Improvement, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dopamine (DA) is a neurotransmitter that plays an important role in brain physiology. Changes in DA-mediated signaling have been implicated with the pathophysiology of various neuropsychiatric conditions. Bipolar disorder (BD) is a mental disorder, characterized by alterning between manic/hypomanic and depressive mood. In experimental research, the pharmacological inhibition of DA reuptake using GBR 12909 serves as a tool to elicit BD-like phenotypes. Alternative model organisms, such as the zebrafish (Danio rerio), have been considered important systems for investigating the neurobehavioral changes involved in different neuropsychiatric conditions, including BD. Here, we discuss the use of GBR 12909 as a novel pharmacological strategy to mimic BD-like phenotypes in zebrafish models. We also emphasize the well-conserved DA-mediated signaling in zebrafish and the early expression of dopaminergic biomarkers in the brain, especially focusing on dopamine transporter (DAT), the main target of GBR 12909. Finally, we discuss potential advantages and limitations in the field, the perspectives of using GBR 12909 in BD research, and how distinct validation criteria (i.e., face, predictive, and construct validity) can be assessed in translational approaches using zebrafish-based models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishBipolar DisorderDopamine Plasma Membrane Transport ProteinsDisease Models, AnimalAnimalsPhenotypeDopamine Uptake InhibitorsBehavior, AnimalBrainDopaminePiperazines

Stichwörter der Autor:innen

Bipolar disorderDopamine transporterGBR 12909Neuropsychiatric conditionsZebrafish

Substanzen

Dopamine Plasma Membrane Transport ProteinsvanoxerineDopamine Uptake InhibitorsDopaminePiperazines

Autor:innen und Institutionen

  • Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal University of Santa Maria, 1000 Roraima Avenue, Santa Maria, RS 97105-900, Braz…
  • Department of Food Science and Technology, Center of Rural Sciences, Federal University of Santa Maria, Camobi, Santa Maria, RS 97105-900, Brazil.

Förderung

  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
  • Coordination of Higher Education Personnel Improvement
  • National Council for Scientific and Technological Development

Zitieren

APA

Canzian, J., Borba, J. V., Resmim, C. M., Mohammed, K. A., Pretzel, C. W., Adedara, I. A., & Rosemberg, D. B. (2025). The dopamine transporter inhibition using GBR 12909 as a novel pharmacological tool to assess bipolar disorder-like neurobehavioral phenotypes in zebrafish. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2024.115302

Vancouver

Canzian J, Borba JV, Resmim CM, Mohammed KA, Pretzel CW, Adedara IA, et al. The dopamine transporter inhibition using GBR 12909 as a novel pharmacological tool to assess bipolar disorder-like neurobehavioral phenotypes in zebrafish. Behavioural Brain Research. 2025. doi:10.1016/j.bbr.2024.115302

BibTeX
@article{Canzian2025,
  author = {Canzian, Julia and Borba, João V and Resmim, Cássio M and Mohammed, Khadija A and Pretzel, Camilla W and Adedara, Isaac A and Rosemberg, Denis B},
  title = {The dopamine transporter inhibition using GBR 12909 as a novel pharmacological tool to assess bipolar disorder-like neurobehavioral phenotypes in zebrafish},
  journal = {Behavioural Brain Research},
  year = {2025},
  doi = {10.1016/j.bbr.2024.115302}
}
Kostenlos starten →